Page 13 - Dane Leone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Operator Good day, and thank you for standing by. Welcome to the Galapagos Financial Results Q1 2021 Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your first speaker today, Elizabeth Goodwin. Please go ahead. Elizabeth Goodwin -- Vice President of Investor Relations Thank you all, and welcome to our call today. I'm Elizabeth Goodwin, Investor Relations, and the webcast that we're recording is going to be accessible via the Galapagos website homepage and will be avai...

Markets After Needham and H.C. Wainwright gave G1 Therapeutics (NASDAQ: GTHX) a Buy rating last month, the company received another Buy, this time from Raymond James. Analyst Dane Leone maintained a Buy rating on G1 Therapeutics today. The company’s shares closed last Wednesday at $22.63. According to TipRanks.com, Leone is a 5-star analyst with an average return of 15.6% and a 62.7% success rate. Leone covers the Healthcare sector, focusing on stocks such as Adverum Biotechnologies, Tarsus Pharmaceuticals, and Allogene Therapeutics. G1 Therapeutics has an analyst consensus of Strong Buy, ...

Amgen Inc (AMGN) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Amgen Inc (NASDAQ: AMGN) Operator My name is Erica, and I will be your conference facilitator today for Amgen's First Quarter 2021 Financial Results Conference Call. [Operator Instructions] I would now like to introduce Arvind Sood, Vice President of Investor Relations. Mr. Sood, you may now begin.SPONSORED: 10 stocks we like better than Amgen When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, ...

Markets Bristol Myers (BMY) Raymond James analyst Dane Leone maintained a Buy rating on Bristol Myers today. The company’s shares closed last Friday at $66.01, close to its 52-week high of $67.16. According to TipRanks.com, Leone is a 5-star analyst with an average return of 15.3% and a 62.7% success rate. Leone covers the Healthcare sector, focusing on stocks such as Adverum Biotechnologies, Tarsus Pharmaceuticals, and Allogene Therapeutics. Bristol Myers has an analyst consensus of Strong Buy, with a price target consensus of $76.50, representing a 15.4% upside. In a report issued on Apr...

Cytokinetics Inc (CYTK) Q4 2020 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Cytokinetics Inc (NASDAQ: CYTK) Operator Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics' Fourth Quarter 2020 Conference Call. [Operator Instructions] I will now turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Creations and Investor Relations. Please go ahead. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, th...